A recent study reports that disruption of tracheal basal cell homeostasis is the key cellular event driving lung squamous ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

Professor Sam Janes, senior author of the study from UCL Division of Medicine, said, "In this study, we set out to understand ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

Helene Duhamel was recently diagnosed with non-small cell squamous cell lung cancer. Duhamel shares her thoughts on her ...

Non-small-cell lung cancer ... are characterized by cancer cells that grow and spread in different ways. The three most common forms of NSCLC are adenocarcinoma, squamous cell carcinoma and ...

This includes the airways in your lungs. One clinical trial of Opdivo involved adults with squamous non-small cell lung cancer (NSCLC). Researchers found that people with squamous NSCLC who took ...

Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 87% of cases. NSCLCs can be broken down into 2 major sub-types: adenocarcinoma (sometimes referred to as ...

The antibody-drug conjugate (ADC) is currently under review by the FDA as a treatment for advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) in adults who have undergone prior ...

An independent data monitoring committee has determined that the HARMONi-6 trial for the first-line treatment of advanced squamous non-small cell lung cancer (NSCLC) has met its primary endpoint ...

Image of a lung lobe from a carcinogen-exposed mouse. Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ...